A share price of MEI Pharma Inc [MEIP] is currently trading at $5.19, up 1.76%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MEIP shares have gain 6.57% over the last week, with a monthly amount glided 92.94%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MEI Pharma Inc [NASDAQ: MEIP] stock has seen the most recent analyst activity on July 23, 2024, when Laidlaw downgraded its rating to a Hold. Previously, Wells Fargo downgraded its rating to Equal Weight on March 25, 2022, and dropped its price target to $2. On March 25, 2022, downgrade downgraded it’s rating to Hold and revised its price target to $2 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $1 on March 25, 2022. Jefferies initiated its recommendation with a Buy and recommended $4 as its price target on February 03, 2022. Alliance Global Partners started tracking with a Buy rating for this stock on September 22, 2020, and assigned it a price target of $9. In a note dated May 29, 2020, SunTrust initiated an Buy rating and provided a target price of $16 on this stock.
MEI Pharma Inc experienced fluctuations in its stock price throughout the past year between $1.46 and $9.00. MEI Pharma Inc [NASDAQ: MEIP] shares were valued at $5.19 at the most recent close of the market.
Analyzing the MEIP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.52, Equity is -1.27 and Total Capital is -1.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for MEI Pharma Inc [NASDAQ:MEIP] is 16.78. In addition, the Quick Ratio stands at 16.78 and the Cash Ratio stands at 16.54.
Transactions by insiders
Recent insider trading involved Anson Funds Management LP, Former 10% Stockholder, that happened on Jul 28 ’25 when 1.09 million shares were purchased. Former member of group that ow, Funicular Funds, LP completed a deal on Jul 23 ’25 to buy 0.61 million shares.
